abnormal kidney morphology, abnormal megakaryocyte morphology, abnormal megakaryocyte progenitor cell morphology, abnormal placental labyrinth vasculature morphology, abnormal podocyte foot process morphology, abnormal proerythroblast morphology, abnormal renal glomerulus morphology, abnormal splenic cell ratio, abnormal thymus morphology, absent common myeloid progenitor cells, absent visceral yolk sac blood islands, absent vitelline blood vessels, decreased body size, decreased bone marrow cell number, decreased embryo size, decreased hair follicle number, decreased hematocrit, decreased hemoglobin content, decreased mean corpuscular hemoglobin concentration, decreased mean corpuscular volume, decreased survivor rate, delayed heart looping, dilated dorsal aorta, disorganized yolk sac vascular plexus, distended pericardium, embryonic growth arrest, embryonic growth retardation, embryonic lethality, embryonic lethality between implantation and somite formation, complete penetrance, embryonic lethality during organogenesis, complete penetrance, embryo tissue necrosis, focal hair loss, fused podocyte foot processes, hematopoietic system phenotype, hypoxia, impaired hematopoiesis, incomplete embryo turning, incomplete somite formation, increased hematopoietic stem cell number, increased lymphoblastic lymphoma incidence, increased neuron apoptosis, increased red blood cell distribution width, increased spleen weight, lethality throughout fetal growth and development, incomplete penetrance, pale yolk sac, pericardial edema, premature death, ruffled hair, skin edema